The world as we know it is changing. Especially the western world, as our customs and values are evolving with the new wave of adult citizens; the millennials have grown up! In America, one of the biggest changes we’ve seen is the way our country handles marijuana. What was once before a drug (still is save for the illegal connotation) has now become a medicine that aids millions of people with their conditions, and a recreational substance that is legal like cigarettes and alcohol. As of right now, twenty four states have legalized the medical use of marijuana. Of those twenty four, four of them have legalized the recreational use. Soon, most suspect the other states will follow suit (the marijuana industry will hit 6.7 billion in sales this year). As the industry continues to boom, many companies are trying to feed off the market’s disruption. We’re here to list ten of the most promising and best marijuana stocks recommended for investment. Wherever there is change, there is opportunity.
Cara Therapeutics Inc. (NASDAQ: CARA):
Cara Therapeutics is a biopharmaceutical company developing commercial medicine with the thesis of trying to alleviate pain and pruritus by selectively targeting kappa opioid receptors. Their most advanced compound, called CR845 is currently being tested on its ability to curb pain and pruritus. They own the patent and have already shown early signs of success – gearing up for a promising future.
Canopy Growth Corporation. (Tokyo Stock Exchange: CGC):
Canopy Growth is the parent company that owns Tweed, Tweed Farms Inc., and Bedrocan brands. Canopy Growth is a Canadian company which produces and sells both cannabis oils and edibles. Due to the network of Canopy Growth’s sister companies, the future for them looks very bright. Particularly now that Prime Minister Justin Trudeau has declared he’ll soon push for the legalization of marijuana, so they can tax and regulate the industry. There is a large possibility that legal marijuana use, and a surge of sales in Canada is right around the corner.
GW Pharmaceuticals. (NASDAW: GWPH):
GW is a British biotechnology firm which creates pain medicine from the compounds found in cannabis. They’ve created a multiple sclerosis treatment product which has proven effective. With their consistent successes and new developments (attempting to treat children with severe cases of epilepsy) they were able to raise $250 million in funding on Wall Street this year. As we become more and more advocative of marijuana-related medicine, this is certainly a company to keep an eye on.
Terra Tech. (OTCMKTS: TRTC):
Terra Tech is based in Newport Beach, California – it’s the only publicly traded American company that encapsulate the full spectrum of marijuana and its uses. They have four subsidiaries in different segments of the industry. They have everything from lavish edible products, to Whoopi Goldberg’s cannabis which is supposed to help with menstrual cramps. Thing about this stock is – it’s an OTC and nearly not qualified to be a penny stock at that. However, it’s probably the most established entity in that space – so if you’re a high risk taker, Terra is the one for you.
Scotts Miracle-Gro (NYSE: SMG):
In 2013, Miracle-Gro was reborn after Jim Hagedorn (CEO) decided it was time to go after cannabis growers. Taking into consideration that the company’s shares increased by 13% just last year, it’s safe to say that the company is heading in the right direction. As of now, they’ve invested over $200 million in different areas of cannabis growing. They’re now fully concentrated on the cannabis market and hope to grow alongside it. They’re even researching a brand that designs pesticides specifically for pot. They’re all in with this new push, beckoning us to be, too.
AbbVie. (NYSE: ABBV):
AbbVie made top news for a bit with its recent acquisitions of two established cancer companies. But it’s really their drug Marinol that gets all the attention (in regards to pot). Marinol has already been approved by the FDA and has been proven to work: it helps chemotherapy patients with their nausea and reactivates AIDS patients’ hunger. Even though it doesn’t announce sales of Marinol, any new developments on legalization can give it the push it needs. And it’s got a nice little dividend payout, which makes it a bit more attractive for the long term investors.
Insys Therapeutics (NASDAQ: INSY):
This company essentially sells two drugs: Subsys, a spray used for cancer pain, and Syndros, a medicine used to help with nausea during chemotherapy. Although the stock did drop after investigations went into the sales and marketing of Subsys – and the sales were $24 million less than the initial projection (also wildly due to the public attention on the U.S. opioid epidemic) it still beat its estimate in the first-quarter and had an increase in share profits.
Pineapple Express Inc (OTCMKTS: PNPL):
Pineapple Express functions through one of its subsidiaries (Better Business Consultants) , which basically obtains capital for canna-businesses, and offers an array of services and product innovations for different companies. It’s basically trying to ‘monopolize’ the parent seat of the industry and just as well create a branded chain of marijuana retail stores (under its own name of course). It currently sells a highly integrated and specialized Top-Shell display system for marijuana sales (the system provides security, access, and weighing all in one). It’s been an incredible stock during this year with shares up more than 520% YTD.
Novus Acquisition & Development (OTCMKTS: NDEV):
This Miami-based consulting company basically creates medical plans (cost-saving) for people who want to do unorthodox, alternative treatments for their conditions: particularly cannabis. Their subscription service is cheap and affordable, coming in at under $20 a month. It’s now contracted another company to grow and dispense its patient’s medicine, and has implemented its plan to states where marijuana is legal.
Abattis Bioceuticals Corp (OCTMKTS: ATTBF):
This company from Vancouver, B.C., provides a list of different cultivation systems, extraction equipment, and consulting for growers. They recently raised $3 million in private funding and went on to buy a bunch of different holdings in separate companies (including a fertilizer formula). It looks like they’re on the up and up, looking to expand.
Alternate Cannabis Investing Ideas
“By owning cannabis real estate you have a controllable variable amid various methods of investments with tried and true results. It’s a safer way to entrust your money, plus property values have been booming since 2013, according to a recent article in the New York Times. Entrepreneurs are transforming their spaces into suitable plots for cannabis use. Brick and mortar investments are beating out the retail business because it doesn’t “touch the plant” and is viewed as a safe way to make money from the growing industry. In cities that legalized production, prices of industrial spaces used for cannabis purposes have doubled, and sometimes tripled immediately after the laws passed.” – Rick Payne, Cannabis Real Estate Consultants
The growing marijuana industry creates a vast pool of opportunity. The more the world continues to push for the legalization of marijuana and exploits its medical benefits, the more these companies will continue to grow, expand, and help shape the marketplace. It doesn’t look like we’re going to be shutting down legalization, rather the latter – so keep your eyes peeled for these new emerging companies, as there’s a chance the market doubles in size in the near future. In which case, you’ll be glad to have read up on the best marijuana stocks.